Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Cancer Research Society Doctoral Research Awards - CBCI

University of British Columbia

$35,000.00

Repurposing the angiotensin II receptor blocker Telmisartan to promote anti-tumour immune responses

FY 2024-25

Program
Cancer Research Society Doctoral Research Awards - CBCI
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
511207
Name
Clark Meredith
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Cancer Research Society Inc.; Cancer Research Society Inc.
Instname2
Cancer Research
Prcname2
Special Cases
Projecttitle
Repurposing the angiotensin II receptor blocker Telmisartan to promote anti-tumour immune responses
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$35,000
Cihrequipment2
$0
Programname2
Cancer Research Society Doctoral Research Awards - CBCI
Keyworddelim
Angiotensin Ii; Cancer; Immune Response
Competitiondate
202404
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Clark, Meredith
Approvedterm
2 ans 0 mois
Cihrcontribution2
ICR~ $35,000~ $0~